This study focuses on the Medical Isotope Production Reactor (MIPR), an aqueous homogeneous reactor utilized for synthesizing medical isotopes like ⁹⁹Mo. A pivotal aspect of MIPR’s functionality involves the fuel solution’s complex chemical interactions, particularly during reactor operation. These interactions result in the formation of precipitates, notably studtite and columnar uranium ore, which can impact reactor performance. The research presented here delves into the reactions between liquid fuel uranyl nitrate and key radiolytic products, employing simulation calculations complemented by experimental validation. This approach facilitates the identification of uranium precipitate types and their formation conditions under operational reactor settings. Additionally, the article explores strategies to mitigate the formation of specific uranium precipitates, thereby contributing to the efficient and stable operation of MIPR.

There were two errors in the original publication